Evaluating LC–MS/MS To Measure Accumulation of Compounds within Bacteria

Efflux
DOI: 10.1021/acsinfecdis.8b00083 Publication Date: 2018-06-30T16:28:28Z
ABSTRACT
A general method for determining bacterial uptake of compounds independent antibacterial activity would be a valuable tool in drug discovery. LC-MS/MS assays have been described, but it has not shown whether the data can used directly to inform medicinal chemistry. We describe evaluation an assay measuring association with bacteria, using set over hundred (inhibitors NAD-dependent DNA ligase, LigA) which vitro potency and had determined. All were active against efflux-deficient strain Escherichia coli reduced LigA (E. ligA251 ΔtolC). Testing single compound concentration incubation time, we found that, equipotent compounds, values predictive activity. This indicates that measured bacteria-associated was necessarily exposed target enzyme. Our suggest while exclusion from bacteria is major reason poor potent distribution within cell may also problem. The relative importance these factors likely vary one chemical series another. observations provide directions further study this difficult issue.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (66)
CITATIONS (40)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....